Reata Pharmaceuticals Inc...

NASDAQ: RETA · Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM

Reata Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.42 -3.22
PEG Ratio
-0.91 -0.28
PS Ratio
622.68 83.36
PB Ratio
-21 -0.76
P/FCF Ratio
-6.65 -4.04
P/OCF Ratio
-6.76 -4.06
OCF/S Ratio
-92.18 -20.51
Debt / Equity Ratio
-1.82 -0.11
Quick Ratio
6.75 11.05
Current Ratio
6.75 11.05
Asset Turnover
0.00 0.02
Interest Coverage
-6.47 -4.6
Return on Equity
4.75 0.24
Return on Assets
-0.61 -0.4
Return on Invested Capital
-0.59 -0.36
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
1.00 1.00
Net Profit Margin
-140.75 -25.88
Pretax Profit Margin
-140.76 -25.92
Operating Profit Margin
-121.91 -21.3
FCF Margin
n/a n/a
EBITDA Margin
-121.4 -21.19